Yamamoto Takehito, Uchida Yoichiro, Yano Jo, Nakano Reo, Oshimo Yoshiki, Fujimoto Takashi, Hisano Koji, Nakano Kenzo, Kawai Takayuki, Okuchi Yoshihisa, Iguchi Kohta, Tanaka Eiji, Fukuda Meiki, Taura Kojiro, Terajima Hiroaki
Department of Gastroenterological Surgery and Oncology, Medical Research Institute Kitano Hospital, Kita-ku, Osaka, Japan.
Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
J Vasc Access. 2025 Sep;26(5):1482-1488. doi: 10.1177/11297298241279063. Epub 2024 Sep 26.
Peripherally inserted central catheters (PICCs) are safe and useful alternatives to centrally inserted central catheters (CICCs). Several studies have investigated the effectiveness and safety of PICCs; however, few have focused on their use in patients with gastroenterological diseases. In the present study, we evaluated the outcomes of patients with gastroenterological diseases who received PICCs and identified the risk factors associated with central line-associated blood stream infection (CLABSI).
We retrospectively examined hospitalized patients at our institution who received PICCs between 2015 and 2023. We evaluated the data on their clinical characteristics, complications, and outcomes. Furthermore, we investigated the risk factors for CLABSIs.
A total of 405 patients were included (262 men and 143 women). The median age was 71 (range, 15-94) years. The vessels were inserted in the basilic, cephalic, and brachial veins in 366 (90%), 22 (6%), and 17 (4%) patients, respectively. The median procedure time was 32 [6-149] min. The median dwell time was 16 [0-188] days. CLABSI, catheter occlusions, phlebitis, and exit-site skin infection occurred in 14 (3.5%; 1.77/1000 catheter days), 6 (1.5%; 0.76/1000 catheter days), 3 (0.7%; 0.38/1000 catheter days), and 1 (0.2%; 0.13/1000 catheter days) patients, respectively. There was no case of deep vein thrombosis or pulmonary thrombosis due to PICC placement. Multivariate analysis performed using a Cox's proportional hazard regression model revealed that patients with gastroenterological malignancies had an independently higher risk for CLABSIs (odds ratio [OR]: 3.25, 95% confidence interval [CI]: 1.05-10.05, = 0.041) and that older age (⩾70 years) tended to be associated with CLABSIs (OR: 3.61, 95% CI: 0.98-13.32, = 0.054).
Gastroenterological malignancies and older age were associated with a higher risk of CLABSIs. Rigorous catheter management is crucial for preventing complications, particularly in vulnerable patient subgroups.
外周静脉穿刺中心静脉导管(PICC)是中心静脉穿刺中心静脉导管(CICC)安全且有用的替代方案。多项研究探讨了PICC的有效性和安全性;然而,很少有研究关注其在胃肠疾病患者中的应用。在本研究中,我们评估了接受PICC的胃肠疾病患者的结局,并确定了与中心静脉导管相关血流感染(CLABSI)相关的危险因素。
我们回顾性研究了2015年至2023年在我院接受PICC的住院患者。我们评估了他们的临床特征、并发症和结局数据。此外,我们调查了CLABSI的危险因素。
共纳入405例患者(男性262例,女性143例)。中位年龄为71岁(范围15 - 94岁)。分别有366例(90%)、22例(6%)和17例(4%)患者的导管插入贵要静脉、头静脉和肱静脉。中位操作时间为32[6 - 149]分钟。中位留置时间为16[0 - 188]天。CLABSI、导管堵塞、静脉炎和出口部位皮肤感染分别发生在14例(3.5%;1.77/1000导管日)、6例(1.5%;0.76/1000导管日)、3例(0.7%;0.38/1000导管日)和1例(0.2%;0.13/1000导管日)患者中。没有因PICC置管导致深静脉血栓或肺血栓的病例。使用Cox比例风险回归模型进行的多因素分析显示,胃肠恶性肿瘤患者发生CLABSI的独立风险更高(比值比[OR]:3.25,95%置信区间[CI]:1.05 - 10.05,P = 0.041),且年龄较大(≥70岁)往往与CLABSI相关(OR:3.61,95% CI:0.98 - 13.32,P = 0.054)。
胃肠恶性肿瘤和高龄与CLABSI的较高风险相关。严格的导管管理对于预防并发症至关重要,特别是在易发生并发症的患者亚组中。